Back to search
FDAFDA · Food and drugs·Recall number Z-1694-2018

Straumann® Emdogain 015, USA. Enamel Matrix Derivative. Article Number 075.099

Published May 16, 2018 · Recall initiated: March 23, 2018

Summary

FDA records medical device Class II recall Z-1694-2018, published May 16, 2018 and initiated March 23, 2018. Recalling firm: Straumann Manufacturing, Inc.; Status: Terminated; Reported quantity: 3046; Lot: Lot LT830, Syringe Blister Lot LK692B, Exp 5/31/2018 Lot LZ706, Syringe Blister Lot LK692B, Exp 5/31/2018 Lot MG929, Syringe Blister Lot LK692B, Exp 5/31/2018 Lot MT037, Syringe Blister Lot MG253A, Exp 9/30/2018 Lot MZ441, Syringe Blister Lot MG253A, Exp 9/30/2018 Lot NJ289, Syringe Blister Lot MG253A, Exp 9/30/2018 Lot NJ579, Syringe Blister Lot NA438A, Exp 3/31/2019 Lot NP340, Syringe Blister Lot NA438A, Exp 3/31/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A change regarding the shelf life of a raw material was implemented without an appropriate submission of data demonstrating the continued efficacy of the product.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Straumann Manufacturing, Inc.
Distributor
Distributed US Nationwide and Puerto Rico.
Lot
Lot LT830, Syringe Blister Lot LK692B, Exp 5/31/2018 Lot LZ706, Syringe Blister Lot LK692B, Exp 5/31/2018 Lot MG929, Syringe Blister Lot LK692B, Exp 5/31/2018 Lot MT037, Syringe Blister Lot MG253A, Exp 9/30/2018 Lot MZ441, Syringe Blister Lot MG253A, Exp 9/30/2018 Lot NJ289, Syringe Blister Lot MG253A, Exp 9/30/2018 Lot NJ579, Syringe Blister Lot NA438A, Exp 3/31/2019 Lot NP340, Syringe Blister Lot NA438A, Exp 3/31/2019
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Straumann® Emdogain 015, USA. Enamel Matrix Derivative. Article Number 075.099 recalled?

Yes. FDA published recall Z-1694-2018 on May 16, 2018. Reported hazard: A change regarding the shelf life of a raw material was implemented without an appropriate submission of data demonstrating the continued efficacy of the product.

What should I do if I have this product?

Voluntary: Firm initiated · Letter